Jacqueline Snider

7.9k total citations · 2 hit papers
13 papers, 3.4k citations indexed

About

Jacqueline Snider is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jacqueline Snider has authored 13 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Jacqueline Snider's work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (6 papers) and Estrogen and related hormone effects (3 papers). Jacqueline Snider is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (6 papers) and Estrogen and related hormone effects (3 papers). Jacqueline Snider collaborates with scholars based in United States, Canada and Austria. Jacqueline Snider's co-authors include Matthew J. Ellis, Joel S. Parker, Sherri R. Davies, Charles M. Perou, Samuel Leung, Torsten O. Nielsen, Philip S. Bernard, Maggie C.U. Cheang, David Voduc and Mark Watson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jacqueline Snider

13 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

2009 1.6k citations Maggie C.U. Cheang, Stephen Chia et al. JNCI Journal of the National Cancer Institute profile →
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

2010 542 citations Torsten O. Nielsen, Joel S. Parker et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Jacqueline Snider

Since Specialization

Citations

This map shows the geographic impact of Jacqueline Snider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Snider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Snider more than expected).

Fields of papers citing papers by Jacqueline Snider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Snider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Snider. The network helps show where Jacqueline Snider may publish in the future.

Co-authorship network of co-authors of Jacqueline Snider

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Snider. A scholar is included among the top collaborators of Jacqueline Snider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Snider. Jacqueline Snider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer 2020 ·UNC Libraries ·Chanpheng Phommaly, Robert J. Crowder, Jeremy Hoog, Charles M. Perou, Jacqueline Snider, John A. Olson, Melinda A. Miller, Sherri R. Davies, Yu Tao, Joel S. Parker, Lin Li, Jingqin Luo, Jason D. Weber, Mark A. Watson, David G. Huntsman, Anthony J. Saporita, Matthew J. Ellis	3
2	Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers 2016 ·Nature Communications ·Christopher A. Miller, Yevgeniy Gindin, Charles Lu, Obi L. Griffith, Malachi Griffith, Dong Shen, Jeremy Hoog, Tiandao Li, David E. Larson, Mark A. Watson, Sherri R. Davies, Kelly K. Hunt, Vera J. Suman, Jacqueline Snider, Thomas Walsh, Graham A. Colditz, Katherine DeSchryver, Richard K. Wilson, Elaine R. Mardis, Matthew J. Ellis	51
3	An mRNA Gene Expression–Based Signature to Identify FGFR1-Amplified Estrogen Receptor–Positive Breast Tumors 2016 ·Journal of Molecular Diagnostics ·Jingqin Luo, Shuzhen Liu, Samuel Leung, Alejandro A. Gru, Tao Yu, Jeremy Hoog, Julie Ho, Sherri R. Davies, D. Craig Allred, Andrea L. Salavaggione, Jacqueline Snider, Elaine R. Mardis, Torsten O. Nielsen, Matthew J. Ellis	11
4	Development and verification of the PAM50-based Prosigna breast cancer gene signature assay 2015 ·BMC Medical Genomics ·Brett Wallden, James J. Storhoff, Torsten O. Nielsen, Naeem Dowidar, Carl Schaper, Sean Ferree, Shuzhen Liu, Samuel Leung, Gary Geiss, Jacqueline Snider, Tammi L. Vickery, Sherri R. Davies, Elaine R. Mardis, Michael Gnant, Ivana Šestak, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard, Joel S. Parker	337
5	Estrogen Receptor Expression Is High but Is of Lower Intensity in Tubular Carcinoma Than in Well-Differentiated Invasive Ductal Carcinoma 2014 ·Archives of Pathology & Laboratory Medicine ·Julie M. Jorns, Dafydd G. Thomas, Patrick Healy, Stephanie Daignault, Tammi L. Vickery, Jacqueline Snider, Elaine R. Mardis, Sherri R. Davies, Matthew J. Ellis, Daniel W. Visscher	2
6	Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031 2011 ·Journal of Clinical Oncology ·Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Lin Li, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary Unzeitig, Julie Margenthaler, Gildy V. Babiera, P. Kelly Marcom, Joseph M. Guenther, Mark A. Watson, Marilyn Leitch, Kelly K. Hunt, John A. Olson	365
7	A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer breakdown → 2010 ·Clinical Cancer Research ·Torsten O. Nielsen, Joel S. Parker, Samuel Leung, D. Voduc, Mark Ebbert, Tammi L. Vickery, Sherri R. Davies, Jacqueline Snider, Inge J. Stijleman, Jerry P. Reed, Maggie C.U. Cheang, Elaine R. Mardis, Charles M. Perou, Philip S. Bernard, Matthew J. Ellis	542
8	PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer 2009 ·Cancer Research ·Robert J. Crowder, Chanpheng Phommaly, Tao Yu, Jeremy Hoog, Jingqin Luo, Charles M. Perou, Joel S. Parker, Melinda A. Miller, David G. Huntsman, Lin Li, Jacqueline Snider, Sherri R. Davies, John A. Olson, Mark A. Watson, Anthony J. Saporita, Jason D. Weber, Matthew J. Ellis	174
9	Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer 2009 ·Breast Cancer Research and Treatment ·Matthew J. Ellis, Lin Li, Robert J. Crowder, Tao Yu, Jeremy Hoog, Jacqueline Snider, Sherri R. Davies, Katherine DeSchryver, Dean B. Evans, Jutta Steinseifer, Raj Bandaru, Weihua Liu, Humphrey Gardner, Semiglazov Vf, Mark A. Watson, Kelly K. Hunt, John A. Olson, José Baselga	110
10	Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer breakdown → 2009 ·JNCI Journal of the National Cancer Institute ·Maggie C.U. Cheang, Stephen Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri R. Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen	1641
11	Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer 2009 ·Proceedings of the National Academy of Sciences ·Carrie R. Graveel, (unknown), Yanli Su, Julie Koeman, Karl Dykema, Samuel Leung, Jacqueline Snider, Sherri R. Davies, Pamela J. Swiatek, Sandra Cottingham, Mark A. Watson, Matthew J. Ellis, Robert E. Sigler, Kyle A. Furge, George F. Vande Woude	91
12	Submicromolar Concentrations of Palmitoyl-CoA Specifically Thioesterify Cysteine 244 in Glyceraldehyde-3-phosphate Dehydrogenase Inhibiting Enzyme Activity: A Novel Mechanism Potentially Underlying Fatty Acid Induced Insulin Resistance 2005 ·Biochemistry ·Jingyue Yang, Beverly Gibson, Jacqueline Snider, Christopher M. Jenkins, Xianlin Han, Richard W. Gross	34
13	A Pneumatic Device for Rapid Loading of DNA Sequencing Gels 1998 ·Genome Research ·(unknown), (unknown), (unknown), Jacqueline Snider, (unknown), (unknown), Richard K. Wilson, Elaine R. Mardis	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact